| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.034 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |